Press release from Companies
Publicerat: 2024-07-15 08:00:00
OSLO, NORWAY - July 15, 2024: Microbiome DX company Genetic Analysis AS ("GA" or the "Company") hereby announces that the direct issue which was announced in a press release on the 01.07.2024 has now been registered with the Norwegian Register of Business Enterprises (No. Foretaksregisteret).
GA announced that a direct issue was completed on the 01.07.2024 This provided the Company with approximately NOK 4.97 million by issuance of 6 625 916 new shares, before issue costs. The direct issue has now been registered with the Norwegian Register of Business Enterprises.
After this, the Company's new registered share capital is NOK 29 269 962,60 divided into 48 783 271 shares, each with a nominal value of NOK 0.60.
For more information, please contact:
Eilert Aamodt, Chief Financial Officer
E-mail: ea@genetic-analysis.com
